To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
Ubiquitinated-K266 VDAC1 Antibody
Antibody
Monoclonal antibody directed against ubiquitinated-K266 VDAC1. This antibody failed development due to a lack of sensitivity.
DELE1 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse DELE1. Developed for use in immunoblotting and immunocytochemistry applications. Anticipated Availability: Q4 2027
GALC Antibody
Antibody
Rabbit monoclonal antibody directed against human GALC. Developed for use in immunocytochemistry and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Anticipated Availability: Q4 2027
Glucosylsphingosine Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse glucosylsphingosine. Developed for use in immunoblotting and immunocytochemistry applications. Anticipated Availability: Q4 2027
Glucosylceramide Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse glucosylceramide. Developed for use in immunoblotting and immunocytochemistry applications. Anticipated Availability: Q4 2027
Alpha-Synuclein Ubiquitinated at K45/48/60 Antibody
Antibody
Rabbit monoclonal antibody directed against the K45/48/60-ubiquitinated alpha-synuclein. Estimated Availability: Early 2026
CaV1.3 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse CaV1.3. Developed for use in immunoblotting, immunocytochemistry, immunohistochemistry, and immunoprecipitation applications. This antibody development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2027
TRPML1 Antibody
Antibody
Rabbit monoclonal antibody directed against mouse TRPML1. Developed for use in immunoblotting and immunocytochemistry applications. This antibody development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2027
USP30 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse USP30. Developed for use in immunocytochemistry, immunohistochemistry, and immunoprecipitation applications. This antibody development project is part of the MJFF Targets to Therapies (T2T) Initiative. Anticipated Availability: Q4 2027
Auxilin Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse auxilin for immunostaining applications. Estimated Availability: Mid 2026
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic